We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
-3.58%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$18.5B
AUM Growth
-$797M
(-4.1%)
Cap. Flow
+$398M
Cap. Flow
% of AUM
2.15%
Top 10 Holdings %
Top 10 Hldgs %
9.66%
Holding
1,697
New
297
Increased
468
Reduced
599
Closed
333
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$276M |
| 2 |
Meta Platforms (Facebook)
META
|
+$224M |
| 3 |
Microsoft
MSFT
|
+$177M |
| 4 |
Nike
NKE
|
+$133M |
| 5 |
Coca-Cola
KO
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$213M |
| 2 |
Apple
AAPL
|
+$185M |
| 3 |
PayPal
PYPL
|
+$169M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$104M |
| 5 |
Blackrock
BLK
|
+$95.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Healthcare | 12.99% |
| 3 | Consumer Discretionary | 11.59% |
| 4 | Financials | 10.5% |
| 5 | Industrials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Netflix
NFLX
$324B
| – | – |
-1,717,960
| Closed | -$30M |
|
1552
Nektar Therapeutics
NKTR
$2.58B
| – | – |
-12,789
| Closed | -$729K |
|
1553
Novanta
NOVT
$6.33B
| – | – |
-21,628
| Closed | -$2.62M |
|
1554
ServiceNow
NOW
$132B
| – | – |
-50,410
| Closed | -$4.79M |
|
1555
Insperity
NSP
$2.05B
| – | – |
-23,161
| Closed | -$2.31M |
|
1556
NETGEAR
NTGR
$656M
| – | – |
-79,852
| Closed | -$1.48M |
|
1557
Intellia Therapeutics
NTLA
$1.66B
| – | – |
-99,379
| Closed | -$5.14M |
|
|
NTST
1558
NETSTREIT Corp
NTST
$2.1B
| – | – |
-83,096
| Closed | -$1.57M |
|
1559
Nu Skin
NUS
$235M
| – | – |
-28,821
| Closed | -$1.25M |
|
1560
NovoCure
NVCR
$2.06B
| – | – |
-62,818
| Closed | -$4.37M |
|
1561
Orion
OEC
$367M
| – | – |
-26,571
| Closed | -$413K |
|
1562
O-I Glass
OI
$1.06B
| – | – |
-90,218
| Closed | -$1.26M |
|
1563
Olema Pharmaceuticals
OLMA
$913M
| – | – |
-11,106
| Closed | -$45K |
|
|
OLO
1564
DELISTED
Olo Inc
OLO
| – | – |
-21,866
| Closed | -$216K |
|
1565
OptimizeRx
OPRX
$164M
| – | – |
-19,545
| Closed | -$535K |
|
1566
Oracle
ORCL
$450B
| – | – |
-1,036,793
| Closed | -$72.4M |
|
1567
Organogenesis Holdings
ORGO
$233M
| – | – |
-363,189
| Closed | -$1.77M |
|
1568
Oramed Pharmaceuticals
ORMP
$182M
| – | – |
-20,868
| Closed | -$96K |
|
1569
Occidental Petroleum
OXY
$57.7B
| – | – |
-1,506,317
| Closed | -$88.7M |
|
1570
Pacific Biosciences
PACB
$364M
| – | – |
-220,926
| Closed | -$976K |
|
1571
Penske Automotive Group
PAG
$14.3B
| – | – |
-28,638
| Closed | -$3M |
|
1572
Paycom
PAYC
$10B
| – | – |
-28,054
| Closed | -$7.86M |
|
1573
Prestige Consumer Healthcare
PBH
$2.42B
| – | – |
-20,483
| Closed | -$1.2M |
|
1574
Procore
PCOR
$9.3B
| – | – |
-40,192
| Closed | -$1.82M |
|
1575
Vaxcyte
PCVX
$8.81B
| – | – |
-12,475
| Closed | -$271K |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q3 2022 Portfolio in Review
As of Q3 2022, Voloridge Investment Management held 1,697 positions worth $18.5B, down 4.1% from $19.3B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Voloridge Investment Management's Q3 2022 filing shows 297 new, 468 increased, 599 reduced and 333 closed positions. Its largest new stake was Linde: 388,955 shares worth $105M. The largest sale was Tesla, an estimated $213M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Voloridge Investment Management's largest Q3 2022 buy was Linde: 388,955 shares worth $105M.
- Voloridge Investment Management added most to Adobe in Q3 2022, an estimated $276M increase.
- Voloridge Investment Management's biggest Q3 2022 reduction was Tesla, cutting an estimated $213M.
- Voloridge Investment Management fully exited Apple in Q3 2022, selling an estimated $185M.
- Voloridge Investment Management's ten largest holdings make up 9.7% of its $18.5B portfolio in Q3 2022.
- Voloridge Investment Management opened 297 new positions and closed 333 in Q3 2022.
- Voloridge Investment Management's portfolio value fell 4.1% quarter-over-quarter to $18.5B.
Based on Voloridge Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.